EUVIMEDEUVIMED entdecken
Crossref

Correction of posaconazole concentrations for hypoalbuminemia

David E Nix iD, Fekade Sime iD, Jason A Roberts iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2025

DOI: 10.1002/phar.70021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2025. Verfasst von David E Nix und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, Arizona, USA. Hauptthemen laut MEDLINE: Triazoles, Hypoalbuminemia, Antifungal Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Posaconazole is an example of a highly protein‐bound drug (>98%) in which therapeutic drug monitoring (TDM) is commonplace. Total drug concentration is typically measured, and in the setting of hypoalbuminemia, total concentrations are lower despite no anticipated change in unbound concentration. Data support that unbound posaconazole concentration is responsible for antifungal activity and, in theory, is responsible for adverse effects that are dose‐related. However, the therapeutic range of posaconazole is expressed as total concentration. The objective of this study was to investigate the use of an equation to correct posaconazole concentrations for albumin concentration as a surrogate for measurement of unbound concentration.

Methods

Data on unbound and total posaconazole concentration were acquired retrospectively from a study of posaconazole pharmacokinetics in critically ill patients. The relationship between total and unbound concentration was explored with and without albumin as a covariate using linear regression. Correction equations were used to normalize total concentration to an albumin concentration of 4.4 g/dL.

Results

A total of 78 pairs of total and unbound concentrations were available. Total and unbound posaconazole concentrations were determined using ultra‐high‐performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS). The median fraction unbound was 0.00645 (interquartile range of 0.00331–0.00794). Albumin concentration plays a highly significant role in the interpretation of TDM results. In a patient with hypoalbuminemia, a corrected concentration ( C corr ) = C t /(0.01 + 0.99·Alb/4.4), where C t is the total concentration and Alb is the albumin concentration in units of g/dL, is suggested. This equation can be further simplified to C sim = C t ·4.4/Alb, where C sim is a close approximation of C corr .

Conclusions

Hypoalbuminemia is associated with lower total concentrations of posaconazole; however, the “active” unbound concentration is not expected to systematically change. As a result, total posaconazole concentrations in the therapeutic range for patients with hypoalbuminemia are more likely to be associated with toxicity, especially when doses are increased to achieve “therapeutic” concentrations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesHypoalbuminemiaAntifungal AgentsHumansRetrospective StudiesDrug MonitoringMaleFemaleTandem Mass SpectrometryMiddle AgedChromatography, High Pressure LiquidAgedCritical Illness

Stichwörter der Autor:innen

posaconazoleprotein bindingtherapeutic drug monitoringtoxicityunbound concentration

Substanzen

posaconazoleTriazolesAntifungal Agents

Autor:innen und Institutionen

  • Department of Pharmacy Practice and Science, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, Arizona, USA.
  • University of Queensland Centre for Clinical Research, Faculty of Health, Medicine and Behavioral Sciences, The University of Queensland, Brisbane, Queensland, Australia.
  • Herston Infectious Diseases Institute (HeIDI), Metro North Health, Bisbane, Queensland, Australia.
  • Department of Intensive Care Medicine and Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • UR-UM103 IMAGINE, University Montpellier, Division of Anesthesia Critical Care, Pain and Emergency Medicine, Nimes University Hospital, Montpellier, France.

ORCID-Profile: David E Nix, Fekade Sime, Jason A Roberts

Zitieren

APA

Nix, D. E., Sime, F., & Roberts, J. A. (2025). Correction of posaconazole concentrations for hypoalbuminemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.70021

Vancouver

Nix DE, Sime F, Roberts JA. Correction of posaconazole concentrations for hypoalbuminemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2025. doi:10.1002/phar.70021

BibTeX
@article{Nix2025,
  author = {Nix, David E and Sime, Fekade and Roberts, Jason A},
  title = {Correction of posaconazole concentrations for hypoalbuminemia},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2025},
  doi = {10.1002/phar.70021}
}
Kostenlos starten →